KYORIN Holdings, Inc. (4569.T)

JPY 1448.0

(0.49%)

Long Term Debt Summary of KYORIN Holdings, Inc.

  • KYORIN Holdings, Inc.'s latest annual long term debt in 2023 was 435 Million JPY , down -95.99% from previous year.
  • KYORIN Holdings, Inc.'s latest quarterly long term debt in 2024 Q1 was 385 Million JPY , down -11.49% from previous quarter.
  • KYORIN Holdings, Inc. reported annual long term debt of 10.84 Billion JPY in 2022, down -2.99% from previous year.
  • KYORIN Holdings, Inc. reported annual long term debt of 11.17 Billion JPY in 2021, down -2.34% from previous year.
  • KYORIN Holdings, Inc. reported quarterly long term debt of 10.53 Billion JPY for 2023 Q2, down -0.48% from previous quarter.
  • KYORIN Holdings, Inc. reported quarterly long term debt of 485 Million JPY for 2023 Q3, down -95.4% from previous quarter.

Annual Long Term Debt Chart of KYORIN Holdings, Inc. (2023 - 2004)

Historical Annual Long Term Debt of KYORIN Holdings, Inc. (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 435 Million JPY -95.99%
2022 10.84 Billion JPY -2.99%
2021 11.17 Billion JPY -2.34%
2020 11.44 Billion JPY -12.31%
2019 13.05 Billion JPY 333.62%
2018 3.01 Billion JPY -30.37%
2017 4.32 Billion JPY 5.23%
2016 4.1 Billion JPY -8.08%
2015 4.46 Billion JPY 78.47%
2014 2.5 Billion JPY 399.8%
2013 501 Million JPY 15.17%
2012 435 Million JPY 20.5%
2011 361 Million JPY -21.52%
2010 460 Million JPY -28.35%
2009 642 Million JPY -43.39%
2008 1.13 Billion JPY 0.53%
2007 1.12 Billion JPY 40.47%
2006 803 Million JPY -29.0%
2005 1.13 Billion JPY 0.0%
2004 - JPY 0.0%

Peer Long Term Debt Comparison of KYORIN Holdings, Inc.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 64.663%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.99%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.674%
Shionogi & Co., Ltd. 8.75 Billion JPY 95.03%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Nippon Shinyaku Co., Ltd. 1.15 Billion JPY 62.24%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.677%
Morishita Jintan Co., Ltd. 106 Million JPY -310.377%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -472.368%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 93.804%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 96.74%
Tsumura & Co. 54.37 Billion JPY 99.2%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -1877.273%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.77%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 96.352%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 94.524%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 84.13%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 90.683%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -1511.111%
Modalis Therapeutics Corporation 412.5 Million JPY -5.455%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 90.344%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 99.349%
Cyfuse Biomedical K.K. 345 Million JPY -26.087%
Toho Holdings Co., Ltd. 28.16 Billion JPY 98.456%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 72.665%